中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

2015 No. 1

Display Method:
Editorial
Traditional Chinese medicine treatment of liver diseases
Wang RongBing
2015, 31(1): 2-6. DOI: 10.3969/j.issn.1001-5256.2015.01.001
Abstract:
Traditional Chinese medicine(TCM) treatment of liver diseases is derived from the regulation of liver function including storing blood and governing the free flow of qi,in which functional systems such as modern digestion,endocrine,and the gut-liver axis are involved,and is established on modern hep...
Therapeutic guidelines
Chinese consensus on the medical diagnosis and treatment of chronic cholecystitis and gallstones (2014, Shanghai)
Editorial Board of Chinese Journal of Digestion
2015, 31(1): 7-11. DOI: 10.3969/j.issn.1001-5256.2015.01.002
Abstract(3924) PDF (1558KB)(1091)
Abstract:
Diagnosis and treatment of cholangiocarcinoma: surgical expert consensus  
Chinese Chapter of International Hepato-Pancreato-Biliary Association,Hepatic Surgery Group, Chinese Society of Surgery, Chinese Medical Association
2015, 31(1): 12-16. DOI: 10.3969/j.issn.1001-5256.2015.01.003
Abstract(3434) PDF (1685KB)(1264)
Abstract:
Guidelines for the management of acute pancreatitis(2014)
Group of Pancreas Surgery, Chinese Society of Surgery, Chinese Medical Association
2015, 31(1): 17-20. DOI: 10.3969/j.issn.1001-5256.2015.01.004
Abstract(275) PDF (192KB)(1998)
Abstract:
Recommendations of ACG clinical guideline: the diagnosis and management of focal liver lesions
Zhu Peng, Chen Zhan, Wang YuMing
2015, 31(1): 21-24. DOI: 10.3969/j.issn.1001-5256.2015.01.005
Abstract:
Expert interpretation of the “KASL Clinical Practice Guidelines: Management of hepatitis C”
Ding Yang, Dou XiaoGuang
2015, 31(1): 25-29. DOI: 10.3969/j.issn.1001-5256.2015.01.006
Abstract:
Interpretation of the practice guidelines for alcoholic liver disease by EASL in 2012 and AASLD in 2010
Chang BinXia, Sun Ying, Teng GuangJu, Zhang Wei, Zhao Jun, Zou ZhengSheng, Li BaoSen
2015, 31(1): 30-34. DOI: 10.3969/j.issn.1001-5256.2015.01.007
Abstract:
Discussions by experts
Strategy for traditional Chinese medicine prevention and treatment of chronic hepatitis B
Gao YueQiu
2015, 31(1): 35-37. DOI: 10.3969/j.issn.1001-5256.2015.01.008
Abstract:

Abundant experience has been accumulated when it comes to the traditional Chinese medicine(TCM) prevention and treatment of chronic hepatitis B(CHB).However,there still exist some deficiencies such as insufficient randomized controlled trials(RCTs) and lack of attention to objective indices for ther...

Progress and prospect of diagnosis and treatment of hepatic fibrosis by integrated traditional Chinese and Western medicine therapy
Wang XianBo, Sun Le
2015, 31(1): 38-41. DOI: 10.3969/j.issn.1001-5256.2015.01.009
Abstract:

In recent years,non-invasive methods for assessment of hepatic fibrosis have attracted more and more attention,and the application of non-invasive diagnostic techniques such as serum markers and transient elastography(Fibro Scan) for hepatic fibrosis is reviewed.Anti-fibrosis treatments should integ...

Clinical research progress in integrated traditional Chinese and Western medicine therapy for HBV-related liver failure
Li Jun
2015, 31(1): 42-47. DOI: 10.3969/j.issn.1001-5256.2015.01.010
Abstract:
Currently,hepatitis B virus(HBV)-related acute-on-chronic liver failure(ACLF) and chronic liver failure(CLF) are the main clinical types of liver failure.This disease has complex,changeable,and accompanying syndromes,so the treatment is very difficult.In recent years,some progress has been made in t...
Study on TCM syndromes of liver failure and yang-supporting therapy
Mao DeWen, Tang Nong, Wang Na, Wang Sha, Long FuLi, Yi MinMing
2015, 31(1): 48-51. DOI: 10.3969/j.issn.1001-5256.2015.01.011
Abstract:
This paper reviews traditional Chinese medicine(TCM) physicians' understanding of liver failure including its TCM causes,mechanisms,positions,and syndrome differentiation in various dynasties.The results suggest that modern researchers agree with ancient physicians on these aspects of liver failure....
Progress in integrated traditional Chinese and Western medicine diagnosis and treatment for advanced schistosomiasis
Wu Liang, Tian DeYing
2015, 31(1): 52-57. DOI: 10.3969/j.issn.1001-5256.2015.01.012
Abstract:
Schistosomiasis is a dangerous infectious disease,and advanced schistosomiasis is a serious harm to people' s lives and health.Anthelmintic treatment alone cannot effectively prevent the development and progression of advanced schistosomiasis,especially liver fibrosis.This article introduces the pat...
Original articles_Integrated traditional and western medicine on hepatopancteatobiliary disease
Effect of kidney-tonifying and spleen-strengthening prescription on PD-1 and PD-L1 expression in HBeAg-positive chronic hepatitis B patients with slightly increased ALT levels
Zhou ZhenHua, Sun XueHua, Li Man, Zhu XiaoJun, Jin ShuGen, Zhang Xin, Gao YaTing, Gao YueQiu
2015, 31(1): 58-62. DOI: 10.3969/j.issn.1001-5256.2015.01.013
Abstract:

Objective To study the effect of kidney-tonifying and spleen-strengthening prescription(KTSSP) on the expression of programmed death-1(PD-1) and programmed death-ligand 1(PD-L1) in HBe Ag-positive chronic hepatitis B(CHB) patients with slightly increased alanine aminotransferase(ALT) levels.Methods ...

Efficacy of glycyrrhizin in patients with chronic severe hepatitis B:a meta-analysis
Mao HaiYing, Kang Tao, Yao Ling, Chen Qin
2015, 31(1): 63-67. DOI: 10.3969/j.issn.1001-5256.2015.01.014
Abstract:

Objective To systematically evaluate the efficacy and safety of glycyrrhizin in patients with chronic severe hepatitis B.Methods Literature published from January 1990 to July 2014 were searched in databases including Pub Med,Cochrane Library,CBMdisc,CNKI,VIP,and Wanfang Data.The randomized controll...

Clinical efficacy of traditional Chinese medicine/herbal decoction combined with ursodeoxycholic acid for primary biliary cirrhosis:a meta-analysis
Du Ying, Fang Lei
2015, 31(1): 68-73. DOI: 10.3969/j.issn.1001-5256.2015.01.015
Abstract:

Objective To systematically evaluate the efficacy of traditional Chinese medicine / herbal decoction combined with ursodeoxycholic acid(UDCA) in the treatment of primary biliary cirrhosis(PBC),and to provide a reference for clinical medication.Methods Literature published before July 31,2014 was sea...

Clinical efficacy of Zisheng pills in treatment of adverse reactions in patients with primary hepatocellular carcinoma after transcatheter arterial chemoembolization
Liu XiaPing, Tao Yu, Wu ChunMing, Chen YongPing
2015, 31(1): 74-77. DOI: 10.3969/j.issn.1001-5256.2015.01.016
Abstract:

Objective To investigate the clinical efficacy of Zisheng pills in the treatment of adverse reactions in patients with primary hepatocellular carcinoma(HCC) after transcatheter arterial chemoembolization(TACE).Methods This study included 72 patients with liver cancer hospitalized in the Department o...

Efficacy of Chaowei Zhikangyin in treatment of rat model of non-alcoholic fatty liver disease
Xiong Yan, Zhang ZhiJuan, Liu Peng, Wang Ya
2015, 31(1): 78-81. DOI: 10.3969/j.issn.1001-5256.2015.01.017
Abstract:

Objective To observe the efficacy of Chaowei Zhikangyin in the treatment of the rat model of non-alcoholic fatty liver disease(NAFLD).Methods A rat model of NAFLD was established by feeding 50 Sprague-Dawley rats with high-fat diet for 6 weeks and was confirmed by liver pathological examination.Then...

Original articles_Fatty liver
An epidemiological survey of prevalence and risk factors for fatty liver disease in adults residing in Yan'an,China
Qiao LiNa, Dai GuangRong, Zhang Jin, Shen Ni
2015, 31(1): 82-87. DOI: 10.3969/j.issn.1001-5256.2015.01.018
Abstract:

Objective To investigate the prevalence and major risk factors for fatty liver disease among adult residents in Yan'an,Shanxi Province,China.Methods The study enrolled healthy adults who had physical examination with complete clinical records in our hospital from February 2011 to March 2013.All part...

Original articles_Biliary diseases
Expression and significance of UCP-2 in rats with obstructive jaundice and bile flow restoration
Wen Nuan, Zhu YiXiang, Lu: RenGeng, Kang JiangHui, Han HongJun, Xu HanBin
2015, 31(1): 88-92. DOI: 10.3969/j.issn.1001-5256.2015.01.019
Abstract:

Objective To investigate the expression and significance of uncoupling protein 2(UCP-2) in rats with obstructive jaundice and bile flow restoration,and to explore the molecular mechanisms of metabolic disorders and oxidative damage caused by obstructive jaundice.Methods Thirty-six healthy male Wista...

Original articles_Hepatopancreatobiliary tumor
Diagnostic value of combined determination of DNA ploidy level and miRNA-21 expression in ascites cells for hepatocellular carcinoma
Xiao ZuoHan, Meng Gang, Wang LiZhi, Sun WenJin
2015, 31(1): 93-98. DOI: 10.3969/j.issn.1001-5256.2015.01.020
Abstract:

Objective To evaluate the diagnostic value of combined determination of DNA ploidy level and microRNA-21(miRNA-21)expression in ascites cells for hepatocellular carcinoma(HCC).Methods A total of 117 patients with ascites admitted to our hospital from January 1,2012 to January 1,2014 were enrolled.Th...

Clinical effect of transcatheter arterial chemoembolization combined with argon-helium cryoablation in patients with advanced unresectable primary hepatocellular carcinoma
Ni MingLi
2015, 31(1): 99-102. DOI: 10.3969/j.issn.1001-5256.2015.01.021
Abstract:

Objective To evaluate the efficacy and safety of transcatheter arterial chemoembolization(TACE) combined with argon-helium cryoablation in patients with advanced unresectable primary hepatocellular carcinoma(HCC).Methods TACE was performed in 35 patients with primary HCC who were admitted to our hos...

Original articles_Others
Diagnosis and treatment of pyogenic liver abscess in elderly patients by multislice CT
Wang YuLin, Hu RongKui, Zong Min
2015, 31(1): 103-106. DOI: 10.3969/j.issn.1001-5256.2015.01.022
Abstract:

Objective To review the multislice computed tomography(MSCT) characteristics and treatment of pyogenic liver abscess in elderly patients.Methods A retrospective analysis was performed on the clinical data of 42 elderly patients who were diagnosed with pyogenic liver abscess in our hospital from Marc...

Brief reports
Efficacy of low-dose interferon α-1b combined with ribavirin and thymosin α1 versus standard treatment for chronic hepatitis C: a comparative study 
Sun JianMin
2015, 31(1): 107-109. DOI: 10.3969/j.issn.1001-5256.2015.01.023
Abstract:
Case reports
Liver damage induced by Polygonum multiflorum powder: a report of 2 cases 
Liu MiaoMiao, Pan LiuLan, Wei YuTong, Xiao HeJun, Duan LiWei
2015, 31(1): 110-111. DOI: 10.3969/j.issn.1001-5256.2015.01.024
Abstract:
A case of primary leiomyosarcoma of the liver and literature review 
Liu ChunHua, Li QingYan, Guan Shan, Wang SiKui
2015, 31(1): 112-114. DOI: 10.3969/j.issn.1001-5256.2015.01.025
Abstract:
Reviews
HCV culture system and its application in antiviral research on Chinese herb extracts in vitro
Li JingTao, Chang ZhanJie, Xi Qi, Liu YaZhu, Song ChunRong, Nan Ran, Li RiXiang, Wei HaiLiang, Yan ShuGuang
2015, 31(1): 115-117. DOI: 10.3969/j.issn.1001-5256.2015.01.026
Abstract:
Many studies have shown that Chinese herb extracts could treat patients who suffer hepatitis C.However,the clinical efficacy is limited due to the use of traditional Chinese medicine(TCM) compounds.Because each drug contains multiple active substances,some of which may even act against each other in...
Research advances in traditional Chinese medicine combined with interventional therapy for hepatocellular carcinoma
Liu Yang, Li GuiYing, Zhao XiangXuan, Lu ZaiMing, Guo QiYong
2015, 31(1): 118-122. DOI: 10.3969/j.issn.1001-5256.2015.01.027
Abstract:
Interventional therapy has become the first choice of non-surgical treatment for hepatocellular carcinoma(HCC) due to its advantages such as little trauma and marked local effect.However,the clinical efficiency is less than expected.One of the possibilities is the resistance of cancer cells to anti-...
New progress in development of animal models of hepatitis C virus infection
Zhu Ting, Nie QingHe
2015, 31(1): 123-126. DOI: 10.3969/j.issn.1001-5256.2015.01.028
Abstract:
An animal model of hepatitis C virus(HCV) infection involves the use of an animal to build the model for simulating the whole process of HCV infection in humans.Establishing an ideal animal model for HCV infection is conducive to study on the pathogenesis of chronic hepatitis C,including virus-host ...
Relationship between intestinal microflora imbalance and nonalcoholic fatty liver disease
Ma RuiJuan, Wu Jing, Zhou YongNing
2015, 31(1): 127-129. DOI: 10.3969/j.issn.1001-5256.2015.01.029
Abstract:
The intestinal microecosystem is composed of natural microflora,intestinal epithelial cells,and intestinal mucosal immune system.Nonalcoholic fatty liver disease(NAFLD) is a metabolic stress-induced liver injury associated with insulin resistance and genetic susceptibility.In recent years,there has ...
Molecular targeted therapy for hepatocellular carcinoma
Shen YiNan, Lu JunHua
2015, 31(1): 130-134. DOI: 10.3969/j.issn.1001-5256.2015.01.030
Abstract:
Hepatocellular carcinoma(HCC) is the most common malignancy in the liver,for which surgical operation remains the primary treatment.However,the surgical treatment is associated with low resection rate and high recurrence rate,which drive studies on the molecule mechanism of initiation,metastasis,and...
Research progress in prediction of clinical outcome in patients with liver failure
Tang ShanHong, Zeng WeiZheng, Jiang MingDe, Fan QuanShui
2015, 31(1): 135-138. DOI: 10.3969/j.issn.1001-5256.2015.01.031
Abstract:
Liver failure is a clinical syndrome with severe disorders of liver cells for biosynthesis,detoxication,excretion,and biological transformation,which presents with coagulation disorders,jaundice,hepatic encephalopathy,and ascites.Liver failure progresses rapidly,so the prediction of clinical outcome...
Main applications of diffusion-weighted magnetic resonance imaging in liver diseases
Chen Juan, Yin HuaBin
2015, 31(1): 139-142. DOI: 10.3969/j.issn.1001-5256.2015.01.032
Abstract:

Liver failure is a clinical syndrome with severe disorders of liver cells for biosynthesis,detoxication,excretion,and biological transformation,which presents with coagulation disorders,jaundice,hepatic encephalopathy,and ascites.Liver failure progresses rapidly,so the prediction of clinical outcome...